NCT05781737View on ClinicalTrials.gov

Inflammatory Bowel Disease and Atherosclerosis Development

Active, not recruitingOBSERVATIONAL

Enrollment

115

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

January 30, 2024

Study Completion Date

January 30, 2025

Conditions

Inflammatory Bowel DiseasesCardiovascular DiseasesInflammationArterial Stiffness

Trial Locations (1)

119991

University Hospital #1, Moscow

All Listed Sponsors

lead

I.M. Sechenov First Moscow State Medical University

OTHER